According to the report by Expert Market Research (EMR), the global colorectal cancer therapeutics market Size reached a value of approximately USD 14.80 billion in 2023. Aided by the robust healthcare infrastructure and increased treatment rates, the market is projected to further grow at a CAGR of 6.4% between 2024 and 2032 to reach a value of USD 25.87 billion by 2032.
Colorectal cancer, which affects the colon or rectum, is the third most common cancer type and the second leading cause of cancer-related deaths worldwide. Therapeutics for colorectal cancer encompass a diverse range of treatment modalities, including surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapies. These interventions play a critical role in cancer management, either as standalone treatments or as part of a comprehensive treatment plan.
The global colorectal cancer therapeutics market growth is primarily driven by the increasing prevalence of colorectal cancer. The need for colorectal cancer therapies has increased in line with growing understanding of colorectal cancer risk factors, such as unhealthy diet, sedentary lifestyle, smoking, and alcohol. Increased access to early detection and screening techniques, which results in greater diagnosis rates and subsequent treatment needs, is another factor driving this increase in demand.
Get a Free Sample Report with Table of Contents- https://www.expertmarketresearch.com/reports/colorectal-cancer-therapeutics-market/requestsample
The market is also stimulated by the growing list of treatments for colorectal cancer. Modern immunotherapies and targeted therapies, as well as conventional chemotherapy and radiation therapy, have considerably expanded the range of therapeutic options available to patients. These developments have increased the effectiveness of colorectal cancer treatments, improving patient quality of life and survival rates.
The increased use of personalised medicine is also driving a surge in demand for colorectal cancer therapies. This strategy involves modifying a patient’s treatment depending on their genetic profile, resulting in more effective and focused therapy. This trend towards personalised medicine in cancer treatment is expected to provide a significant boost to the colorectal cancer therapeutics market expansion.
Additionally, the rising support from government and non-government organisations for cancer research and the development of new therapeutics are contributing to the colorectal cancer therapeutics market development. Increased funding and favourable regulatory policies are encouraging innovation in colorectal cancer therapeutics, leading to the development of more effective and safer treatment options.
Read Full Report with Table of Contents- https://www.expertmarketresearch.com/reports/colorectal-cancer-therapeutics-market
Colorectal Cancer Therapeutics Market Segmentation
The market can be divided based on therapy, cancer type, route of administration, end user, and region.
Market Breakup by Therapy
- Â Targeted Therapy
- Â Immunotherapy
- Â Chemotherapy
- Â Others
Market Breakup by Cancer Type
- Â Colorectal Adenocarcinoma
- Â Gastrointestinal Carcinoid Tumours
- Â Others
Market Breakup by Route of Administration
- Â Oral
- Â Parenteral
- Â Others
Market Breakup by End User
- Â Hospitals
- Â Homecare
- Â Speciality Clinics
- Â Others
Market Breakup by Region
- Â North America
- Â Europe
- Â Asia Pacific
- Â Latin America
- Â Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global colorectal cancer therapeutics companies. Some of the major key players explored in the report by Expert Market Research are as follows:
- Â Genentech, Inc.
- Â Eli Lilly and Company
- Â Bayer AG
- Â Amgen Inc.
- Â F. Hoffmann-La Roche Ltd.
- Â Pfizer Inc
- Â Novartis AG
- Â Accord Healthcare
- Â Alkem Labs Ltd
- Â Bausch Health Companies Inc.
- Â Hill Dermaceuticals, Inc.
- Â Bristol-Myers Squibb Company
- Â Fresenius Kabi USA
- Â Sagent Pharmaceuticals, Inc.
- Â Sanofi
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Jhon Roy, Corporate Sales Specialist – U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
